Metabolic/Bariatric Surgery is Preferable to Incretin-Based Pharmacotherapy in Patients with Severe Obesity and CKD: CON
Kidney360 · 04.06.2026
DOI: 10.34067/kid.0000001278 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney360, online erschienen am 04.06.2026. Verfasst von Phoom Narongkiatikhun und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Endocrinology, Metabolism and Nutrition, University of Washington School of Medicine, Seattle, WA, USA. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Medicine, Division of Endocrinology, Metabolism and Nutrition, University of Washington School of Medicine, Seattle, WA, USA.
- Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
ORCID-Profile: Phoom Narongkiatikhun, Petter Bjornstad
Zitieren
APA
Narongkiatikhun, P., & Bjornstad, P. (2026). Metabolic/Bariatric Surgery is Preferable to Incretin-Based Pharmacotherapy in Patients with Severe Obesity and CKD: CON. Kidney360. https://doi.org/10.34067/kid.0000001278
Vancouver
Narongkiatikhun P, Bjornstad P. Metabolic/Bariatric Surgery is Preferable to Incretin-Based Pharmacotherapy in Patients with Severe Obesity and CKD: CON. Kidney360. 2026. doi:10.34067/kid.0000001278
BibTeX
@article{Narongkiatikhun2026,
author = {Narongkiatikhun, Phoom and Bjornstad, Petter},
title = {Metabolic/Bariatric Surgery is Preferable to Incretin-Based Pharmacotherapy in Patients with Severe Obesity and CKD: CON},
journal = {Kidney360},
year = {2026},
doi = {10.34067/kid.0000001278}
}
EUVIMED